The Heart in FOCUS: FOrging Towards Better CV OUtcomeS video highlights insights from three experts on the time to benefit demonstrated by different statins in clinical trials, emphasizing on atorvastatin being the only statin associated with consistently low levels of LDL-C and early reduction of cardiovascular events. Additionally, the video also featured the legacy benefits of atorvastatin and amlodipine as reported by the ASCOT trial.
You must be a member to access this content.
To become a member, please register here.
If you're already a member, please sign in to access.